{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:59:33Z","timestamp":1789790373655,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:00:00Z","timestamp":1699142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:00:00Z","timestamp":1699142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1245\/s10434-023-14533-w","type":"journal-article","created":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T14:01:33Z","timestamp":1699192893000},"page":"1097-1107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Defining Optimal Management of Non-metastatic Adrenocortical Carcinoma"],"prefix":"10.1245","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6599-0397","authenticated-orcid":false,"given":"Jesse E.","family":"Passman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajid","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Soegaard Ballester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara P.","family":"Ginzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Wachtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,5]]},"reference":[{"issue":"6","key":"14533_CR1","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1210\/jc.2008-2291","volume":"94","author":"SH Golden","year":"2009","unstructured":"Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009;94(6):1853\u201378.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"14533_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.14740\/jocmr3503w","volume":"10","author":"E Sharma","year":"2018","unstructured":"Sharma E, Dahal S, Sharma P, Bhandari A, Gupta V, Amgai B, Dahal S. The characteristics and trends in adrenocortical carcinoma: a United States population based study. J Clin Med Res. 2018;10(8):636.","journal-title":"J Clin Med Res"},{"issue":"5","key":"14533_CR3","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","volume":"30","author":"E Kebebew","year":"2006","unstructured":"Kebebew E, Reiff E, Duh Q-Y, Clark OH, McMillan A. Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? World J Surg. 2006;30(5):872\u20138.","journal-title":"World J Surg"},{"issue":"11","key":"14533_CR4","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","volume":"72","author":"MD Wooten","year":"1993","unstructured":"Wooten MD, King DK. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer. 1993;72(11):3145\u201355.","journal-title":"Cancer"},{"issue":"17","key":"14533_CR5","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","volume":"322","author":"J-P Luton","year":"1990","unstructured":"Luton J-P, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med. 1990;322(17):1195\u2013201.","journal-title":"N Engl J Med"},{"issue":"2","key":"14533_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","volume":"23","author":"M Fassnacht","year":"2009","unstructured":"Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab. 2009;23(2):273\u201389.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"14533_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else T, Kim AC, Sabolch A, et al. Adrenocortical carcinoma. Endocr Rev. 2014;35(2):282\u2013326.","journal-title":"Endocr Rev"},{"issue":"5","key":"14533_CR8","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/1097-0142(20010901)92:5<1113::AID-CNCR1428>3.0.CO;2-I","volume":"92","author":"R Vassilopoulou-Sellin","year":"2001","unstructured":"Vassilopoulou-Sellin R, Schultz PN. Adrenocortical carcinoma: clinical outcome at the end of the 20th century. Cancer. 2001;92(5):1113\u201321.","journal-title":"Cancer"},{"issue":"11","key":"14533_CR9","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1002\/cncr.23886","volume":"113","author":"KY Bilimoria","year":"2008","unstructured":"Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, Sturgeon C. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer. 2008;113(11):3130\u20136.","journal-title":"Cancer"},{"issue":"1","key":"14533_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.soc.2015.08.011","volume":"25","author":"J Datta","year":"2016","unstructured":"Datta J, Roses RE. Surgical management of adrenocortical carcinoma: an evidence-based approach. Surg Oncol Clin. 2016;25(1):153\u201370.","journal-title":"Surg Oncol Clin"},{"issue":"6","key":"14533_CR11","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/S0039-6060(97)90229-4","volume":"122","author":"R Bellantone","year":"1997","unstructured":"Bellantone R, Ferrante A, Boscherini M, et al. Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery. 1997;122(6):1212\u20138.","journal-title":"Surgery"},{"issue":"4","key":"14533_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s40618-015-0422-4","volume":"39","author":"F Porpiglia","year":"2016","unstructured":"Porpiglia F, Fiori C, Daffara F, et al. Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome? J Endocrinol Investig. 2016;39(4):465\u201371.","journal-title":"J Endocrinol Investig"},{"issue":"4S","key":"14533_CR13","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.juro.2010.02.069","volume":"183","author":"F Porpiglia","year":"2010","unstructured":"Porpiglia F, Fiori C, Daffara F, Zaggia B, Scarpa RM, Terzolo M. Does nephrectomy during radical adrenalectomy for adrenocortical cancer affect oncological results? J Urol. 2010;183(4S):e11\u2013e11.","journal-title":"J Urol"},{"key":"14533_CR14","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1245\/s10434-018-6546-y","volume":"25","author":"P Marincola Smith","year":"2018","unstructured":"Marincola Smith P, Kiernan CM, Tran TB, et al. Role of additional organ resection in adrenocortical carcinoma: analysis of 167 patients from the US adrenocortical carcinoma database. Ann Surg Oncol. 2018;25:2308\u201315.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"14533_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.surg.2011.09.030","volume":"152","author":"S Gaujoux","year":"2012","unstructured":"Gaujoux S, Brennan MF. Recommendation for standardized surgical management of primary adrenocortical carcinoma. Surgery. 2012;152(1):123\u201332.","journal-title":"Surgery"},{"issue":"2","key":"14533_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/cancers14020291","volume":"14","author":"A Hendricks","year":"2022","unstructured":"Hendricks A, M\u00fcller S, Fassnacht M, Germer C-T, Wiegering VA, Wiegering A, Reibetanz J. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma: a systematic review and meta-analysis. Cancers. 2022;14(2):291.","journal-title":"Cancers"},{"issue":"3","key":"14533_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-019-0773-7","volume":"21","author":"S Jasim","year":"2019","unstructured":"Jasim S, Habra MA. Management of adrenocortical carcinoma. Curr Oncol Rep. 2019;21(3):1\u201311.","journal-title":"Curr Oncol Rep"},{"issue":"23","key":"14533_CR18","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMoa063360","volume":"356","author":"M Terzolo","year":"2007","unstructured":"Terzolo M, Angeli A, Fassnacht M, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med. 2007;356(23):2372\u201380.","journal-title":"N Engl J Med"},{"issue":"12","key":"14533_CR19","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, Rosen JE, Mallin K, et al. Using the national cancer database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722\u20138.","journal-title":"JAMA Oncol"},{"issue":"6","key":"14533_CR20","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1245\/s10434-019-07213-1","volume":"26","author":"K Mallin","year":"2019","unstructured":"Mallin K, Browner A, Palis B, et al. Incident cases captured in the National Cancer Database compared with those in US population based central cancer registries in 2012\u20132014. Ann Surg Oncol. 2019;26(6):1604\u201312.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"14533_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/SLA.0b013e3182367ac3","volume":"255","author":"J Reibetanz","year":"2012","unstructured":"Reibetanz J, Jurowich C, Erdogan I, et al. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma. Ann Surg. 2012;255(2):363\u20139.","journal-title":"Ann Surg"},{"issue":"5","key":"14533_CR22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1245\/s10434-016-5536-1","volume":"23","author":"JM Gerry","year":"2016","unstructured":"Gerry JM, Tran TB, Postlewait LM, et al. Lymphadenectomy for adrenocortical carcinoma: Is there a therapeutic benefit? Ann Surg Oncol. 2016;23(5):708\u201313.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"14533_CR23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1055\/s-0035-1549877","volume":"47","author":"N Saade","year":"2015","unstructured":"Saade N, Sadler C, Goldfarb M. Impact of regional lymph node dissection on disease specific survival in adrenal cortical carcinoma. Horm Metab Res. 2015;47(11):820\u20135.","journal-title":"Horm Metab Res"},{"key":"14533_CR24","volume-title":"Release 17 [computer program]","author":"Stata Statistical Software","year":"2021","unstructured":"Stata Statistical Software. Release 17 [computer program]. College Station: StataCorp LLC; 2021."},{"issue":"5","key":"14533_CR25","doi-asserted-by":"publisher","first-page":"497.e491","DOI":"10.1016\/j.clgc.2022.04.011","volume":"20","author":"KB Ginsburg","year":"2022","unstructured":"Ginsburg KB, Chandra AA, Handorf EA, et al. Association of surgical approach with treatment burden, oncological effectiveness, and perioperative morbidity in adrenocortical carcinoma. Clin Genitourin Cancer. 2022;20(5):497.e491-497.","journal-title":"Clin Genitourin Cancer"},{"key":"14533_CR26","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/jso.26845","volume":"125","author":"M Shah","year":"2022","unstructured":"Shah M, NeMoyer RE, Kashyap R, et al. Surgical resection for adrenocortical carcinoma: current trends affecting survival. J Surg Oncol. 2022;125:1224\u201330.","journal-title":"J Surg Oncol"},{"issue":"3","key":"14533_CR27","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1245\/s10434-021-11051-5","volume":"29","author":"J Tseng","year":"2022","unstructured":"Tseng J, DiPeri T, Chen Y, et al. Adrenocortical carcinoma: the value of lymphadenectomy. Ann Surg Oncol. 2022;29(3):1965\u201370.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"14533_CR28","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1007\/s00464-021-08827-x","volume":"36","author":"JJ Hue","year":"2022","unstructured":"Hue JJ, Ahorukomeye P, Bingmer K, et al. A comparison of robotic and laparoscopic minimally invasive adrenalectomy for adrenal malignancies. Surg Endosc. 2022;36(7):5374\u201381.","journal-title":"Surg Endosc"},{"key":"14533_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jss.2022.04.078","volume":"279","author":"AM Delman","year":"2022","unstructured":"Delman AM, Turner KM, Griffith A, Schepers E, Ammann AM, Holm TM. Minimally invasive surgery for resectable adrenocortical carcinoma: a nationwide analysis. J Surg Res. 2022;279:200\u20137.","journal-title":"J Surg Res"},{"issue":"5","key":"14533_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.jamcollsurg.2008.01.018","volume":"206","author":"J Lee","year":"2008","unstructured":"Lee J, El-Tamer M, Schifftner T, et al. Open and laparoscopic adrenalectomy: analysis of the national surgical quality improvement program. J Am Coll Surg. 2008;206(5):953\u20139.","journal-title":"J Am Coll Surg"},{"issue":"10","key":"14533_CR31","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","volume":"157","author":"L Yip","year":"2022","unstructured":"Yip L, Duh Q-Y, Wachtel H, et al. American association of endocrine surgeons guidelines for adrenalectomy: executive summary. JAMA Surg. 2022;157(10):870\u20137.","journal-title":"JAMA Surg"},{"issue":"4","key":"14533_CR32","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht M, Dekkers OM, Else T, et al. European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. 2018;179(4):G1\u201346.","journal-title":"Eur J Endocrinol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14533-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-14533-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14533-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T15:22:55Z","timestamp":1704208975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-14533-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["14533"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-14533-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,5]]},"assertion":[{"value":"8 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jesse E. Passman, Wajid Amjad, Jacqueline M. Soegaard Ballester, Sara P. Ginzberg, and Heather Wachtel declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}